New NICE guidelines on hypertension treatment
Thousands more people could be eligible for blood pressure lowering medication under the latest NICE guideline on the diagnosis and treatment of hypertension, published today (August 28).
The new recommendations reduce the CVD risk threshold at which treatment for hypertension should be considered. NICE says that treatment should now be offered to patients under the age of 80 years with a diagnosis of stage 1 hypertension who have an estimated 10-year CVD risk of 10 per cent or more. This is a reduction from the 20 per cent CVD risk treatment threshold in previous NICE guidelines.
The new guideline continues to use a blood pressure reading of 140/90mmHg and above as the level used to define hypertension.
High blood pressure affects around 13.5 million people and contributes to 75,000 deaths in England alone, making it the biggest preventable cause of death and disability through strokes, heart attacks and heart failure. Clinical management of hypertension accounts for 12 per cent of visits to primary care and up to £2.1bn of healthcare expenditure.
Over the last decade the average blood pressure in England has fallen by about 3 mmHg systolic and the proportion of adults with untreated high blood pressure has decreased, says NICE. However, Public Health England's Blood Pressure Action Plan has called for additional measures to reduce average blood pressure by a further 5 mmHg through improved prevention, detection and management.
Understand how fungal nail infections develop and help manage customer expectations around treatment
Upgrade your contraceptive consultations by exploring the interactive pack to learn about a daily oral contraceptive pill
Record my learning outcomes
Inspiring stories related to health, fitness and the pursuit of wellbeing
More like this
Support staff training requirements take formal effect
The GPhC set out requirements for the education and training of pharmacy support staff on October 1.
4 Min Article
Lloyds introduces foundation programme for new pharmacists
Newly qualified pharmacists at LloydsPharmacy will be enrolled on to a 12-month development training programme.
2 Min Article
MPs launch inquiry into the impact of pandemic on pharmacy
The All-Party Pharmacy Group is warning that Covid-19 is posing an existential threat to the sector.
2 Min Article
Advising customers of a unique formulation for a blocked and runny nose from colds
Understand the differences between topical medication for nasal symptoms of the common cold, and topical medication for ongoing nasal problems
34 Min Module